Example: Heart Attack

Search clinical trials for: Estrogen Antagonists

Total 1491 results

NCT00728949

Completed

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

Conditions: Metastatic Breast Cancer
NCT02291913

Completed

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

Conditions: Breast Cancer
NCT02648477

Active, not recruiting

Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer

Conditions: Estrogen Receptor Negative; Estrogen Receptor Positive; HER2/Neu Negative; Progesterone Receptor Negative; Progesterone Receptor Positive; Stage IV Breast Cancer; Triple-Negative Breast Carcinoma
NCT00206544

Completed

Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?

Conditions: Bipolar Disorder; Mania; Schizoaffective Disorder
NCT02911844

Completed

Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension

Conditions: Pulmonary Arterial Hypertension
NCT00437359

Terminated

Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer

Conditions: Breast Neoplasms
NCT01556191

Active, not recruiting

Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR

Conditions: Stage IV Lung Cancer
NCT00237198

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Conditions: Postmenopausal Women With Advanced Breast Cancer
NCT01313039

Completed

Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer

Conditions: Breast Cancer
NCT00066339

Completed

Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy

Conditions: Breast Cancer
NCT00887380

Active, not recruiting

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)

Conditions: Breast Cancer
NCT04498520

Not yet recruiting

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Conditions: Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Hormone Receptor Positive Breast Carcinoma; Locally Advanced Breast Carcinoma; Metastatic Breast Carcinoma; Metastatic Endometrioid Adenocarcinoma; Metastatic Fallopian Tube Carcinoma; Metastatic HER2 Negative Breast Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Ovarian Carcinoma; Metastatic Primary Peritoneal Carcinoma; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Refractory Breast Carcinoma; Stage IV Fallopian Tube Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Primary Peritoneal Cancer AJCC v8; Stage IV Uterine Corpus Cancer AJCC v8; Stage IVA Fallopian Tube Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVA Primary Peritoneal Cancer AJCC v8; Stage IVA Uterine Corpus Cancer AJCC v8; Stage IVB Fallopian Tube Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8; Stage IVB Primary Peritoneal Cancer AJCC v8; Stage IVB Uterine Corpus Cancer AJCC v8
NCT02188745

Recruiting

ER Reactivation Therapy for Breast Cancer

Conditions: Metastatic Breast Cancer
NCT00723398

Completed

Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

Conditions: Breast Cancer
NCT01694225

Completed

Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

Conditions: Breast Cancer
NCT00375622

Completed

Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial

Conditions: Hereditary Hemorrhagic Telangiectasia
NCT02513329

Active, not recruiting

Stellate Ganglion Block (SGB) For Women for Breast Cancer

Conditions: Hot Flushes; Hot Flashes
NCT02632045

Recruiting

Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer

Conditions: Metastatic Breast Cancer; Breast Carcinoma
NCT00871858

Unknown status

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer

Conditions: Breast Cancer
NCT02352597

Completed

Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOS

Conditions: Polycystic Ovaries
NCT00005886

Completed

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

Conditions: Breast Cancer
NCT00002864

Completed

Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

Conditions: Breast Cancer
NCT01237327

Completed

Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer

Conditions: Metastatic Breast Cancer
NCT00043069

Completed

Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

Conditions: Osteoporosis; Prostate Cancer
NCT00050141

Completed

Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer

Conditions: Breast Cancer